Guidelines for prescribing generic medicines in public hospitals
The Government has put in place a Uniform Code for Pharmaceutical Marketing Practices (UCPMP) for Pharmaceutical companies, which is in operation since 01.01.2015, to prevent unethical practices by the pharmaceutical companies. This code governs the conduct of pharmaceutical companies in their marketing practices, duly covering the various aspects such as medical representatives, textual and audio-visual […]
LSW LifeScienceWorld lost one of its initial Advisory Board Members and a well-wisher on the 6th December, 2022
LSWLifeScienceWorld lost one of its initial Advisory Board Members and a well-wisher on the 6th December, 2022. Dr. S G A Rao, was our guide and always gave valuable suggestions on the editorial front and contributed articles in the stem cell area which was his specialisation. He conceived the entire program of our interactive meeting […]
WHO and football icons rally to score a goal for “Health for All” to build healthier future
12 December 2022 I Geneva and Doha -- On Universal Health Coverage Day (UHC Day), the World Health Organization (WHO) teams up with international football icons to urge action by governments and people across the world to achieve health for all. UHC ensures that everyone, everywhere can access the support they need to be and […]
Roche presents new data demonstrating the potential benefit of glofitamab and Lunsumio as fixed-duration, off-the-shelf treatment options for lymphoma
Data showcase the potential of glofitamab and Lunsumio to address diverse patient needs. Data presented at ASH 2022 and simultaneously published in the New England Journal of Medicine showed that glofitamab, given as a fixed course, induced early and durable responses in people with heavily pre-treated large B-cell lymphoma. 27-month follow-up data showed Lunsumio continued […]
Roche’s subcutaneous crovalimab given every four weeks achieves disease control in people with PNH, a life-threatening blood condition
The phase III COMMODORE 3 study of crovalimab met primary endpoints of transfusion avoidance and haemolysis control in people with paroxysmal nocturnal hemoglobinuria (PNH). COMMODORE 3 is the first China-specific study in PNH. Current treatment options are extremely limited in China, resulting in significant levels of disease-related morbidity and mortality for people living with PNH. […]
Interim data from phase III study presented at ASH 2022 show Hemlibra achieved meaningful bleed control in infants from birth
The HAVEN 7 study was designed to further confirm the benefit of preventative treatment (prophylaxis) with Hemlibra from birth in previously untreated or minimally treated infants with severe haemophilia A without inhibitors. In the study, 77.8% of participants had no bleeding episodes that required treatment. In addition, real-world efficacy and safety data from the EUHASS […]
Protected: 2-day National Health Ministers’ Conclave on Universal Health Coverage Day 2022 concludes in Varanasi today
There is no excerpt because this is a protected post.
EMBARGOED PRESS RELEASE: GLASS report on antimicrobial resistance: embargoed until 09:00 CET (Geneva time) on 9 December 2022
A new World Health Organization (WHO) report reveals high levels of resistance in bacteria, causing life-threatening bloodstream infections, as well as increasing resistance to treatment in several bacteria causing common infections in the community based on data reported by 87 countries in 2020. For the first time, the Global Antimicrobial Resistance and Use Surveillance System […]
Celebration of Universal Health Coverage (UHC) Day 2022 at Varanasi on 10th December
Union Ministry of Health & Family Welfare is organizing a two days conclave commemorating the “Universal Coverage Day (UHC) 2022” on 10th and 11th December 2022 at Varanasi, Uttar Pradesh. Smt. Anandiben Patel, Hon’ble Governor, Uttar Pradesh will inaugurate the two-day celebrations in presence of Union Minister of Health & Family Welfare, Dr. Mansukh Mandaviya. […]
Roche Alzheimer’s disease Cerebrospinal Fluid (CSF) assays receive FDA clearance, supporting more accurate and timely diagnosis
The Elecsys® Alzheimer’s disease (AD) CSF assays will be available on the cobas fully automated immunoassay analyzers, enabling patients to get broad access to high quality testing in a timely manner. Greater accessibility and lower cost means these assays could accelerate the path to diagnosis for people with Alzheimer’s disease. The assays are easily scalable […]
